Skip to content
OpenCapital
Get started

ResMed RMD Sleep And Breathing Health — Net revenue by segment

Other product segments

Devices
$1.47B+8.8%
Masks and other
$1.05B+15.5%
Residential Care Software
$170.89M+6.0%

Similar metrics at other companies

AdaptHealth logo
AHCOSleep Health — Net revenue
$358.5M+13.3%
AdaptHealth logo
AHCORespiratory Health — Net revenue
$178.14M+7.6%
Perrigo Company logo
PRGOPain & Sleep — Net Sales
$106.6M-17.8%
Jazz Pharmaceuticals logo
JAZZSleep — Revenue from Contract with Customer, Excluding Assessed Tax
$439.4M+15.0%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Net Sales
$595M+10.2%
AdaptHealth logo
AHCOSleep Health — Adjusted EBITDA
$62.7M-1.5%

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%
Free cash flow$520.5M-6.7%

Valuation

See full
Market cap$29.05B-22.6%
Enterprise value$28.5B-23.3%
P/E19.1×-7.7×
P/S5.3×-2.0×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp
FCF margin31.7%+0.4pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's sleep and breathing health — net revenue by segment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's sleep and breathing health — net revenue by segment?
ResMed (RMD) reported sleep and breathing health — net revenue by segment of $1.26B in Q1 2026.
How has ResMed's sleep and breathing health — net revenue by segment changed year-over-year?
ResMed's sleep and breathing health — net revenue by segment increased by 11.5% year-over-year, from $1.13B to $1.26B.
What is the long-term trend for ResMed's sleep and breathing health — net revenue by segment?
Over 2 years (2023 to 2025), ResMed's sleep and breathing health — net revenue by segment has grown at a 10.0% compound annual growth rate (CAGR), from $3.73B to $4.5B.
What does sleep and breathing health — net revenue by segment mean?
Measures the total sales generated by the Sleep and Breathing Health segment after accounting for returns, allowances, and discounts. This is the top-line performance metric for the segment, reflecting market demand for respiratory devices and accessories. It is the primary indicator of the segment's growth trajectory and market share.